Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2091220225Completed
Open-label trial of 5-aminolevulinic acid in gastric cancer (GC) (2 arms), sponsored by Osaka University Hospital. Primary endpoint: Incidence of adverse events by CTCAE grade. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2091220225.